EP2925404A4 - Procédés, dispositifs, et systèmes associés à la surveillance d'analytes - Google Patents

Procédés, dispositifs, et systèmes associés à la surveillance d'analytes

Info

Publication number
EP2925404A4
EP2925404A4 EP13859365.2A EP13859365A EP2925404A4 EP 2925404 A4 EP2925404 A4 EP 2925404A4 EP 13859365 A EP13859365 A EP 13859365A EP 2925404 A4 EP2925404 A4 EP 2925404A4
Authority
EP
European Patent Office
Prior art keywords
methods
devices
systems associated
monitoring analytes
analytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP13859365.2A
Other languages
German (de)
English (en)
Other versions
EP2925404A1 (fr
EP2925404B1 (fr
Inventor
Mark K Sloan
Royce Cheng
Gary A Hayter
Marc B Taub
Mani Gopal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Diabetes Care Inc
Original Assignee
Abbott Diabetes Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Diabetes Care Inc filed Critical Abbott Diabetes Care Inc
Priority to EP23205132.6A priority Critical patent/EP4331659A3/fr
Publication of EP2925404A1 publication Critical patent/EP2925404A1/fr
Publication of EP2925404A4 publication Critical patent/EP2925404A4/fr
Application granted granted Critical
Publication of EP2925404B1 publication Critical patent/EP2925404B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7221Determining signal validity, reliability or quality
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/029Operational features adapted for auto-initiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/08Sensors provided with means for identification, e.g. barcodes or memory chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14503Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1495Calibrating or testing of in-vivo probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physiology (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Emergency Medicine (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
EP13859365.2A 2012-11-29 2013-11-27 Dispositifs et systèmes associés à la surveillance d'analytes Active EP2925404B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP23205132.6A EP4331659A3 (fr) 2012-11-29 2013-11-27 Procédés, dispositifs et systèmes associés à la surveillance d'analytes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261731316P 2012-11-29 2012-11-29
PCT/US2013/072257 WO2014085602A1 (fr) 2012-11-29 2013-11-27 Procédés, dispositifs, et systèmes associés à la surveillance d'analytes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP23205132.6A Division EP4331659A3 (fr) 2012-11-29 2013-11-27 Procédés, dispositifs et systèmes associés à la surveillance d'analytes

Publications (3)

Publication Number Publication Date
EP2925404A1 EP2925404A1 (fr) 2015-10-07
EP2925404A4 true EP2925404A4 (fr) 2016-08-03
EP2925404B1 EP2925404B1 (fr) 2023-10-25

Family

ID=50773854

Family Applications (2)

Application Number Title Priority Date Filing Date
EP13859365.2A Active EP2925404B1 (fr) 2012-11-29 2013-11-27 Dispositifs et systèmes associés à la surveillance d'analytes
EP23205132.6A Pending EP4331659A3 (fr) 2012-11-29 2013-11-27 Procédés, dispositifs et systèmes associés à la surveillance d'analytes

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP23205132.6A Pending EP4331659A3 (fr) 2012-11-29 2013-11-27 Procédés, dispositifs et systèmes associés à la surveillance d'analytes

Country Status (3)

Country Link
US (6) US9872641B2 (fr)
EP (2) EP2925404B1 (fr)
WO (1) WO2014085602A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10360368B2 (en) * 2013-12-27 2019-07-23 Abbott Diabetes Care Inc. Application interface and display control in an analyte monitoring environment
EP3120274A1 (fr) * 2014-03-20 2017-01-25 Quidel Corporation Système sans fil pour surveiller une maladie presque en temps réel
US9901305B2 (en) 2014-06-13 2018-02-27 Medtronic Minimed, Inc. Physiological sensor history backfill system and method
EP3113054B1 (fr) * 2015-07-01 2019-09-04 Roche Diabetes Care GmbH Dispositif portable et procédé de collecte et de traitement de surveillance continue des données indicatives d'un analyte dans un fluide corporel, système médical et produit de programme informatique
ES3036460T3 (en) * 2015-07-01 2025-09-19 Hoffmann La Roche A portable device and a method for processing continuous monitoring data indicative of an analyte in a bodily fluid, a medical system and a computer program product
TWI576677B (zh) * 2015-12-04 2017-04-01 財團法人金屬工業研究發展中心 自動化監測方法、系統與電腦程式產品
EP3435865B1 (fr) * 2016-03-29 2024-10-23 Roche Diabetes Care GmbH Procédé de fonctionnement d'un récepteur pour la réception de données d'analyte, récepteur et produit de programme informatique
US10867700B2 (en) * 2016-07-18 2020-12-15 Theresa R. Marshall Electronic wellness check for establishing medical staff integrity and high functional efficiency
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
US11464459B2 (en) * 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
JP7512203B2 (ja) 2017-12-12 2024-07-08 ビッグフット バイオメディカル インコーポレイテッド 治療支援情報及び/又は追跡装置並びに関連する方法及びシステム
US11197964B2 (en) 2017-12-12 2021-12-14 Bigfoot Biomedical, Inc. Pen cap for medication injection pen having temperature sensor
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
WO2020072463A1 (fr) * 2018-10-01 2020-04-09 Elemental Machines, Inc. Procédé et appareil de détection locale
US12205699B1 (en) 2018-10-30 2025-01-21 Bigfoot Biomedical, Inc. Method of pairing therapy devices using shared secrets, and related systems, methods and devices
US20220020488A1 (en) * 2018-10-31 2022-01-20 Resmed Inc. System and method for varying data volume transmitted to external source
DK3955804T3 (da) 2019-04-18 2024-09-23 Abbott Diabetes Care Inc Systemer, indretninger og fremgangsmåder til håndtering af trådløse kommunikationer i et analytovervågningssystem
US11776684B2 (en) 2019-09-26 2023-10-03 Pacesetter, Inc Method and device for managing energy usage by a medical device
US11540751B1 (en) * 2020-03-25 2023-01-03 Tula Health, Inc. Device networks for chronic health condition management
US12329544B2 (en) 2021-06-28 2025-06-17 Pacesetter, Inc. Method and system for optimizing filter settings of an implantable medical device
CN114785461B (zh) * 2022-06-21 2022-10-14 苏州百孝医疗科技有限公司 用于持续监测系统的数据传输方法及系统
US20240310297A1 (en) * 2023-03-17 2024-09-19 Know Labs, Inc. Method to enhance a non-invasive rf analyte detection device
WO2025101366A1 (fr) 2023-11-06 2025-05-15 Tc1 Llc Système et procédé de détection de pic systolique améliorée diastolique
WO2025136640A1 (fr) 2023-12-22 2025-06-26 Tc1 Llc Systèmes et procédés d'extraction d'encoche dicrotique et de détection d'arythmie basées sur la transformée en ondelettes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090093687A1 (en) * 2007-03-08 2009-04-09 Telfort Valery G Systems and methods for determining a physiological condition using an acoustic monitor
WO2009146445A1 (fr) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Procédé et système fournissant un contrôle glycémique
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
US20100094111A1 (en) * 1998-04-30 2010-04-15 Abbotte Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20100327057A1 (en) * 2009-06-30 2010-12-30 Nellcor Puritan Bennett Llc System and method for linking patient data to a patient and providing sensor quality assurance

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6746A (en) 1849-09-25 Shower-bath
US582A (en) 1838-01-27 Machine-fob
JPS6365845A (ja) * 1986-09-05 1988-03-24 ミノルタ株式会社 オキシメ−タ装置
US5264104A (en) 1989-08-02 1993-11-23 Gregg Brian A Enzyme electrodes
US5320725A (en) 1989-08-02 1994-06-14 E. Heller & Company Electrode and method for the detection of hydrogen peroxide
US5262035A (en) 1989-08-02 1993-11-16 E. Heller And Company Enzyme electrodes
US5720293A (en) * 1991-01-29 1998-02-24 Baxter International Inc. Diagnostic catheter with memory
US5262305A (en) 1991-03-04 1993-11-16 E. Heller & Company Interferant eliminating biosensors
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5320715A (en) 1994-01-14 1994-06-14 Lloyd Berg Separation of 1-pentanol from cyclopentanol by extractive distillation
US5987343A (en) * 1997-11-07 1999-11-16 Datascope Investment Corp. Method for storing pulse oximetry sensor characteristics
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6308089B1 (en) * 1999-04-14 2001-10-23 O.B. Scientific, Inc. Limited use medical probe
US6515273B2 (en) * 1999-08-26 2003-02-04 Masimo Corporation System for indicating the expiration of the useful operating life of a pulse oximetry sensor
AU2001263022A1 (en) 2000-05-12 2001-11-26 Therasense, Inc. Electrodes with multilayer membranes and methods of using and making the electrodes
US6591123B2 (en) * 2000-08-31 2003-07-08 Mallinckrodt Inc. Oximeter sensor with digital memory recording sensor data
AU2002255568B8 (en) 2001-02-20 2014-01-09 Adidas Ag Modular personal network systems and methods
AU2002309528A1 (en) 2001-04-02 2002-10-15 Therasense, Inc. Blood glucose tracking apparatus and methods
US20030208113A1 (en) 2001-07-18 2003-11-06 Mault James R Closed loop glycemic index system
JP2003084101A (ja) 2001-09-17 2003-03-19 Dainippon Printing Co Ltd 光学素子用樹脂組成物、光学素子、およびプロジェクションスクリーン
AU2002350108B2 (en) 2001-11-01 2008-09-11 Scott Laboratories, Inc. User interface for sedation and analgesia delivery systems and methods
US20050101841A9 (en) * 2001-12-04 2005-05-12 Kimberly-Clark Worldwide, Inc. Healthcare networks with biosensors
US7399277B2 (en) 2001-12-27 2008-07-15 Medtronic Minimed, Inc. System for monitoring physiological characteristics
US8152991B2 (en) * 2005-10-27 2012-04-10 Nanomix, Inc. Ammonia nanosensors, and environmental control system
US20050038680A1 (en) 2002-12-19 2005-02-17 Mcmahon Kevin Lee System and method for glucose monitoring
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
US20040158294A1 (en) 2003-02-12 2004-08-12 Medtronic, Inc. Self-powered implantable element
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7970466B2 (en) 2003-10-07 2011-06-28 Medtronic, Inc. Method and apparatus for optimization and assessment of response to extra-systolic stimulation (ESS) therapy
US7278966B2 (en) * 2004-01-31 2007-10-09 Nokia Corporation System, method and computer program product for managing physiological information relating to a terminal user
WO2009048462A1 (fr) 2007-10-09 2009-04-16 Dexcom, Inc. Système d'administration d'insuline intégré avec un capteur de glucose en continu
US8027791B2 (en) 2004-06-23 2011-09-27 Medtronic, Inc. Self-improving classification system
US7905833B2 (en) 2004-07-13 2011-03-15 Dexcom, Inc. Transcutaneous analyte sensor
US20060173260A1 (en) 2005-01-31 2006-08-03 Gmms Ltd System, device and method for diabetes treatment and monitoring
US7848765B2 (en) 2005-05-27 2010-12-07 Where, Inc. Location-based services
WO2006130268A1 (fr) 2005-06-01 2006-12-07 Medtronic, Inc. Correlation d'un ensemble de parametres physiologiques non polysomnographiques avec des etats de sommeil
US9713447B2 (en) * 2005-11-10 2017-07-25 Biovotion Ag Device for determining the glucose level in body tissue
US8868172B2 (en) * 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US20070231846A1 (en) * 2006-04-03 2007-10-04 Cosentino Daniel L Glucose meter communication method and system
US8478406B2 (en) 2006-04-24 2013-07-02 Medtronic, Inc. Apparatus and methods of delivering an enhanced refractory period stimulation therapy
US7684872B2 (en) 2006-04-26 2010-03-23 Medtronic, Inc. Contactless interconnect for transducers
US20070265666A1 (en) 2006-04-27 2007-11-15 Roberts Jonathan P Implantable sensors having high impedance couplings providing current pathways for improved fault tolerance
US20070265674A1 (en) 2006-04-27 2007-11-15 Olson John C Fault tolerant implantable sensors having redundant electrical grounding connections
US20070265671A1 (en) 2006-04-27 2007-11-15 Roberts Jonathan P Selectable switching of implantable sensors to provide fault toleance for implantable medical devices
US20070255353A1 (en) 2006-04-27 2007-11-01 Reinke James D Fault tolerant co-axially wired sensors and methods for implementing same in an implantable medical device
US20070255352A1 (en) 2006-04-27 2007-11-01 Roline Glen M Implantable sensors having current-based switches for improved fault tolerance
US20070265668A1 (en) 2006-04-27 2007-11-15 Reinke James D Fault tolerant sensors and methods for implementing fault tolerance in implantable medical devices
US8323189B2 (en) 2006-05-12 2012-12-04 Bao Tran Health monitoring appliance
US7704227B2 (en) 2006-11-29 2010-04-27 Medtronic Minimed, Inc. Methods and apparatuses for detecting medical device acceleration, temperature, and humidity conditions
US7946985B2 (en) 2006-12-29 2011-05-24 Medtronic Minimed, Inc. Method and system for providing sensor redundancy
US20080221930A1 (en) * 2007-03-09 2008-09-11 Spacelabs Medical, Inc. Health data collection tool
US7894869B2 (en) * 2007-03-09 2011-02-22 Nellcor Puritan Bennett Llc Multiple configuration medical sensor and technique for using the same
US20080234562A1 (en) * 2007-03-19 2008-09-25 Jina Arvind N Continuous analyte monitor with multi-point self-calibration
EP1980195B1 (fr) 2007-04-11 2010-06-16 Given Imaging Ltd. Dispositif de détection in vivo et procédés d'identification correspondants
US7928850B2 (en) * 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8260558B2 (en) * 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
EP2171031B1 (fr) * 2007-06-21 2018-12-05 Abbott Diabetes Care Inc. Dispositifs et procédés de gestion de la santé
US20090036760A1 (en) * 2007-07-31 2009-02-05 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in a medical communication system
WO2009036150A2 (fr) * 2007-09-11 2009-03-19 Aid Networks, Llc Dispositif électronique, sans fil, portable, de surveillance physiologique et de communications de données de patient
KR101432035B1 (ko) * 2007-12-21 2014-08-20 삼성전자주식회사 생체 신호 무선 수신 방법 및 장치
WO2009105709A1 (fr) 2008-02-21 2009-08-27 Dexcom, Inc. Systèmes et procédés pour traiter, transmettre et afficher des données de détecteur
US9560994B2 (en) * 2008-03-26 2017-02-07 Covidien Lp Pulse oximeter with adaptive power conservation
US8976007B2 (en) 2008-08-09 2015-03-10 Brian M. Dugan Systems and methods for providing biofeedback information to a cellular telephone and for using such information
US20100023081A1 (en) 2008-07-28 2010-01-28 Sarah Anne Audet Comprehensive System for Detection of Coronary Syndrome, Cardiac Ischemia and Myocardial Infarction
WO2010088262A2 (fr) * 2009-01-27 2010-08-05 University Of Washington Système de surveillance d'un membre prothétique
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
EP2410910A4 (fr) 2009-03-27 2014-10-15 Dexcom Inc Procédés et systèmes favorisant la gestion du glucose
WO2010127052A1 (fr) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Étalonnage de détecteur d'analyte dynamique sur la base d'un profil de stabilité de détecteur
US20100331631A1 (en) * 2009-06-30 2010-12-30 Nellcor Puritan Bennett Llc Oxygen saturation ear sensor design that optimizes both attachment method and signal quality
EP2473099A4 (fr) * 2009-08-31 2015-01-14 Abbott Diabetes Care Inc Système de surveillance de substance à analyser et procédés de gestion de l'énergie et du bruit
EP4070727B1 (fr) 2009-08-31 2023-07-05 Abbott Diabetes Care, Inc. Affichages pour un dispositif médical
US20110124996A1 (en) 2009-11-20 2011-05-26 Roche Diagnostics Operations, Inc. Diabetes health management systems and methods
US20110184265A1 (en) * 2010-01-22 2011-07-28 Abbott Diabetes Care Inc. Method and Apparatus for Providing Notification in Analyte Monitoring Systems
US9041730B2 (en) 2010-02-12 2015-05-26 Dexcom, Inc. Receivers for analyzing and displaying sensor data
US20110237960A1 (en) * 2010-03-25 2011-09-29 General Electric Company Method, system and apparatus for monitoring patients
AU2011239548A1 (en) 2010-04-16 2012-01-19 Abbott Diabetes Care Inc. Analyte monitoring device and methods
WO2011133768A1 (fr) * 2010-04-22 2011-10-27 Abbott Diabetes Care Inc. Dispositifs, systèmes et procédés liés à la surveillance et la gestion d'analytes
WO2012048168A2 (fr) * 2010-10-07 2012-04-12 Abbott Diabetes Care Inc. Dispositifs et procédés de surveillance d'analyte
EP2632334B1 (fr) * 2010-10-27 2020-09-09 Dexcom, Inc. Dispositif d'enregistrement continu de données de surveillance de substance à analyser pouvant fonctionner en mode aveugle
WO2012068393A1 (fr) * 2010-11-18 2012-05-24 Abbott Diabetes Care Inc. Adaptateur pour système portable sur soi de surveillance de substance à analyser
US20120172891A1 (en) 2010-12-29 2012-07-05 Medtronic, Inc. Implantable medical device fixation testing
US9775982B2 (en) 2010-12-29 2017-10-03 Medtronic, Inc. Implantable medical device fixation
US10112045B2 (en) 2010-12-29 2018-10-30 Medtronic, Inc. Implantable medical device fixation
WO2012108938A1 (fr) 2011-02-11 2012-08-16 Abbott Diabetes Care Inc. Applications logicielles résidant sur des dispositifs portatifs de détermination d'analyte
EP2685895B1 (fr) 2011-03-17 2018-10-10 University of Newcastle Upon Tyne Système pour l'autosurveillance et la régulation de la glycémie
EP3575796B1 (fr) 2011-04-15 2020-11-11 DexCom, Inc. Étalonnage avancé de capteur d'échantillon à analyser et détection d'erreur avancée
US20120323099A1 (en) 2011-04-20 2012-12-20 Medtronic, Inc. Implantable medical device electrode assembly
EP2551784A1 (fr) 2011-07-28 2013-01-30 Roche Diagnostics GmbH Procédé de contrôle de l'affichage d'un ensemble de données
US8514067B2 (en) 2011-08-16 2013-08-20 Elwha Llc Systematic distillation of status data relating to regimen compliance
ES2984055T3 (es) 2011-09-28 2024-10-28 Abbott Diabetes Care Inc Procedimientos para la gestión de monitorización de analitos y gestión de los datos de medición de analitos, y artículos de fabricación relacionados con los mismos
US20130132330A1 (en) 2011-11-22 2013-05-23 Motorola Mobility, Inc. Management of privacy settings for a user device
US9734304B2 (en) * 2011-12-02 2017-08-15 Lumiradx Uk Ltd Versatile sensors with data fusion functionality
US11026600B2 (en) * 2012-01-09 2021-06-08 Invensense, Inc. Activity classification in a multi-axis activity monitor device
US10485435B2 (en) 2012-03-26 2019-11-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter with removeable distal tip
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US20130253342A1 (en) 2012-03-26 2013-09-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter
US9220906B2 (en) 2012-03-26 2015-12-29 Medtronic, Inc. Tethered implantable medical device deployment
US9854982B2 (en) 2012-03-26 2018-01-02 Medtronic, Inc. Implantable medical device deployment within a vessel
US9339197B2 (en) 2012-03-26 2016-05-17 Medtronic, Inc. Intravascular implantable medical device introduction
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US10327714B2 (en) 2012-03-29 2019-06-25 Senseonics, Incorporated Analyte concentration alert function for analyte sensor system
US9414775B2 (en) 2012-03-29 2016-08-16 Senseonics, Incorporated Purification of glucose concentration signal in an implantable fluorescence based glucose sensor
US10111588B2 (en) 2012-03-29 2018-10-30 Senseonics, Incorporated Analyte sensor transceiver configured to provide tactile, visual, and/or aural feedback
US9039876B2 (en) 2012-06-29 2015-05-26 Roche Diagnostics Operations, Inc. Test strip ejector for medical device
US20140052722A1 (en) 2012-08-16 2014-02-20 Dimitris J. Bertsimas Optimization-based regimen method and system for personalized diabetes and diet management
US9351648B2 (en) 2012-08-24 2016-05-31 Medtronic, Inc. Implantable medical device electrode assembly
US9931036B2 (en) 2013-03-14 2018-04-03 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
US10335075B2 (en) 2013-03-14 2019-07-02 Dexcom, Inc. Advanced calibration for analyte sensors
CA2895538A1 (fr) 2013-03-15 2014-09-18 Abbott Diabetes Care Inc. Systeme et procede pour prendre en charge le diabete sur la base de la mediane du glucose, de la variabilite du glucose, et du risque hypoglycemique
EP4736749A2 (fr) 2013-04-30 2026-05-06 Abbott Diabetes Care Inc. Systèmes, dispositifs et procédés d'activation de dispositif électrique éco-énergétique
WO2016049066A1 (fr) 2014-09-23 2016-03-31 Oscillari Llc Capteur de vibrations à base d'un dispositif de surveillance de l'administration de médicaments
CN105793849B (zh) 2013-10-31 2022-08-19 德克斯康公司 用于连续监测装置的自适应界面
US9504425B2 (en) 2013-12-16 2016-11-29 Verily Life Sciences Llc Method of location coordination via wireless protocol between multiple devices
CA2935565C (fr) 2013-12-31 2024-04-16 Senseonics, Incorporated Systeme de surveillance continue d'analytes
US10925536B2 (en) 2014-01-03 2021-02-23 University Of Virginia Patent Foundation Systems of centralized data exchange for monitoring and control of blood glucose
US20170273610A1 (en) 2014-03-12 2017-09-28 Glucovation, Inc Wearable electrochemical sensor and method
US20170185748A1 (en) 2014-03-30 2017-06-29 Abbott Diabetes Care Inc. Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US9459089B2 (en) 2014-04-09 2016-10-04 Qualcomm Incorporated Method, devices and systems for detecting an attachment of an electronic patch
EP3128913B1 (fr) 2014-04-10 2019-05-08 Dexcom, Inc. Détermination d'un indice d'urgence d'utilisateur associé à un état physiologique
EP3167560B1 (fr) 2014-07-07 2021-06-30 Ascensia Diabetes Care Holdings AG Appariement d'appareils amélioré grâce à un composant double-usage et acoustique-piézoélectrique, et à un détecteur de vibration
US20160029931A1 (en) 2014-07-31 2016-02-04 Sano Intelligence, Inc. Method and system for processing and analyzing analyte sensor signals
CA2996475A1 (fr) 2014-09-12 2016-03-17 Blacktree Fitness Technologies Inc. Dispositifs portables et procedes de mesure d'un apport nutritionnel
AU2016219530A1 (en) 2015-02-10 2017-08-10 Dexcom, Inc. Systems and methods for distributing continuous glucose data
US10201295B2 (en) 2015-03-13 2019-02-12 Verily Life Sciences Llc User interactions for a bandage type monitoring device
US9943430B2 (en) 2015-03-25 2018-04-17 Verily Life Sciences Llc Handheld tool for leveling uncoordinated motion
US20160321428A1 (en) 2015-04-29 2016-11-03 Google, Inc. Customizable Health Monitoring
US20160328990A1 (en) 2015-05-07 2016-11-10 Dexcom, Inc. System and method for educating users, including responding to patterns
US9814400B1 (en) 2015-05-26 2017-11-14 Verily Life Sciences Llc Method for improving accuracy of pulse rate estimation
WO2016191715A1 (fr) 2015-05-27 2016-12-01 Senseonics, Incorporated Contrôle d'analytes sans fil
US10159432B1 (en) 2015-06-22 2018-12-25 Verily Life Sciences Llc Detection and evaluation of task performance with a handheld tool
US20170027515A1 (en) 2015-07-30 2017-02-02 Verily Life Sciences Llc Non-Invasive Continuous Monitoring of Physiological Parameters
US10264971B1 (en) 2015-08-28 2019-04-23 Verily Life Sciences Llc System and methods for integrating feedback from multiple wearable sensors
US10209817B1 (en) 2015-11-05 2019-02-19 Google Llc Modular electronic devices
US20170169358A1 (en) 2015-12-09 2017-06-15 Samsung Electronics Co., Ltd. In-storage computing apparatus and method for decentralized machine learning
US10722177B2 (en) 2015-12-18 2020-07-28 Verily Life Sciences Llc Cardiovascular monitoring using combined measurements
US10692011B2 (en) 2016-01-21 2020-06-23 Verily Life Sciences Llc Adaptive model-based system to automatically quantify fall risk
US10470719B2 (en) 2016-02-01 2019-11-12 Verily Life Sciences Llc Machine learnt model to detect REM sleep periods using a spectral analysis of heart rate and motion
EP3435867A4 (fr) 2016-03-30 2019-11-20 Dexcom, Inc. Systèmes, dispositifs et procédés pour un système de surveillance d'un analyte
CA3017255C (fr) 2016-05-02 2023-10-24 Dexcom, Inc. Systeme et procede destines a fournir des alertes optimisees a un utilisateur
US9983418B2 (en) 2016-08-04 2018-05-29 Verily Life Sciences Llc Tactile interface for eye-mountable device
EP3519010B1 (fr) 2016-09-27 2022-01-19 Medtrum Technologies Inc. Procédé garantissant la sécurité d'administration et système médical pouvant être porté utilisant ce procédé
US10154805B2 (en) 2016-10-13 2018-12-18 Verily Life Sciences Llc Disposable glucose biosensor including an activity sensor
US11032855B2 (en) 2016-10-18 2021-06-08 Dexcom, Inc. System and method for communication of analyte data
WO2018120104A1 (fr) 2016-12-30 2018-07-05 Medtrum Technologies Inc. Système et procédé de commande en boucle fermée dans un pancréas artificiel
EP3562380A4 (fr) 2016-12-30 2020-08-12 Medtrum Technologies Inc. Système et procédé de réglage d'algorithme appliquant des capteurs de mouvement dans un système cgm
AU2018230850B2 (en) 2017-03-08 2023-12-14 Abbott Diabetes Care Inc. Systems, devices, and methods for wellness and nutrition monitoring and management using analyte data

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100094111A1 (en) * 1998-04-30 2010-04-15 Abbotte Diabetes Care Inc. Analyte Monitoring Device and Methods of Use
US20090093687A1 (en) * 2007-03-08 2009-04-09 Telfort Valery G Systems and methods for determining a physiological condition using an acoustic monitor
US20090318792A1 (en) * 2007-05-08 2009-12-24 Fennell Martin J Analyte Monitoring System and Methods
WO2009146445A1 (fr) * 2008-05-30 2009-12-03 Abbott Diabetes Care Inc. Procédé et système fournissant un contrôle glycémique
US20100327057A1 (en) * 2009-06-30 2010-12-30 Nellcor Puritan Bennett Llc System and method for linking patient data to a patient and providing sensor quality assurance

Also Published As

Publication number Publication date
US20230255515A1 (en) 2023-08-17
US20210068716A1 (en) 2021-03-11
US20140148659A1 (en) 2014-05-29
US20210068715A1 (en) 2021-03-11
US11633126B2 (en) 2023-04-25
EP4331659A3 (fr) 2024-04-24
WO2014085602A1 (fr) 2014-06-05
US11576593B2 (en) 2023-02-14
US20210169379A1 (en) 2021-06-10
US9872641B2 (en) 2018-01-23
EP2925404A1 (fr) 2015-10-07
EP4331659A2 (fr) 2024-03-06
EP2925404B1 (fr) 2023-10-25
US11633127B2 (en) 2023-04-25
US10806382B2 (en) 2020-10-20
US20180199862A1 (en) 2018-07-19

Similar Documents

Publication Publication Date Title
EP2925404A4 (fr) Procédés, dispositifs, et systèmes associés à la surveillance d'analytes
EP2967344A4 (fr) Dispositifs, systèmes et procédés associés à des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte
EP2680754A4 (fr) Dispositifs, systèmes et procédés associés à des dispositifs de surveillance d'analyte, et dispositifs comprenant lesdits dispositifs de surveillance d'analyte
EP2863971A4 (fr) Dispositifs, systèmes et procédés pour surveillance de l'adhésion et interaction de patient
EP2582886A4 (fr) Dispositifs, systèmes et procédés de surveillance d'infrastructure
EP2923253A4 (fr) Dispositifs, systèmes et procédés d'informatique empathique
EP2804525A4 (fr) Dispositifs, systèmes et procédés d'interface utilisables avec des dispositifs de surveillance de la pression intravasculaire
EP2846690A4 (fr) Dispositifs, systèmes et procédés spirométriques basés sur un son
EP2911642A4 (fr) Systèmes et procédés de surveillance et de régulation de médicament
EP2938252A4 (fr) Dispositifs intravasculaires, systèmes, et procédés associés
EP2742324A4 (fr) Appareil, systèmes et procédés de surveillance de rendements
EP2915180A4 (fr) Systèmes, dispositifs et procédés d'imagerie ptychographique de fourier
EP3195138A4 (fr) Dispositifs, systèmes et procédés d'utilisation et de surveillance de dispositifs médicaux
EP2938271A4 (fr) Dispositifs, systèmes et procédés d'évaluation de vaisseaux
EP2874942A4 (fr) Procédés, systèmes et dispositifs associés à des canaux microfluidiques ouverts
EP2919659A4 (fr) Systèmes d'imagerie multi-modaux, sondes et procédés associés
EP2812708A4 (fr) Dispositifs à nano-entonnoirs fluidiques, procédés associés, systèmes de fabrication et d'analyse
EP3402392A4 (fr) Systèmes et procédés de surveillance d'un patient
EP2683469A4 (fr) Dispositifs de séparation à membrane, systèmes et procédés utilisant ceux-ci, et systèmes et procédés de gestion de données
EP2814380A4 (fr) Systèmes et procédés de surveillance et de diagnostic
EP2822472A4 (fr) Procédés et systèmes de suivi et de guidage de capteurs et d'instruments
EP3057496A4 (fr) Dispositifs, systèmes et procédés intravasculaires
EP2976045A4 (fr) Systèmes, procédés et dispositifs liés à des prothèses de la hanche adaptées à des patients
EP2882373A4 (fr) Dispositifs d'ancrage de greffe, systèmes et procédés
EP2856524A4 (fr) Boîtiers d'éléments électroluminescents, systèmes d'éléments électroluminescents, et procédés

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150605

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/1495 20060101ALI20160630BHEP

Ipc: A61B 5/145 20060101AFI20160630BHEP

Ipc: G06F 19/00 20110101ALI20160630BHEP

Ipc: A61N 1/08 20060101ALI20160630BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200527

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61N0001080000

Ipc: A61B0005145000

Ref country code: DE

Ref legal event code: R079

Ref document number: 602013084852

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61N0001080000

Ipc: A61B0005145000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 1/08 20060101ALI20230331BHEP

Ipc: A61B 5/1495 20060101ALI20230331BHEP

Ipc: A61B 5/145 20060101AFI20230331BHEP

INTG Intention to grant announced

Effective date: 20230503

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013084852

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: FP

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1623818

Country of ref document: AT

Kind code of ref document: T

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240225

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240225

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240126

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240125

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240125

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013084852

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231127

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231130

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20231130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20240726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20231130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20131127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20131127

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20251015

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231025

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20251013

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20251009

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20251013

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20251013

Year of fee payment: 13